Related Experiment Videos
Neonatal hyperbilirubinemia caused by pyruvate kinase deficiency
1Waukesha Memorial Hospital, Medical College of Wisconsin.
Insights
Neonatal hyperbilirubinemia caused by pyruvate kinase deficiency requires prompt evaluation and management. Family practitioners can effectively manage this condition with timely referrals for severe cases.
Area of Science:
- Biochemistry
- Pediatrics
- Hematology
Background:
- Neonatal hyperbilirubinemia is a common condition in newborns.
- Pyruvate kinase deficiency is a rare inherited metabolic disorder affecting red blood cells.
Observation:
- An infant presented with severe jaundice due to pyruvate kinase deficiency.
- Initial management included phototherapy and close monitoring of bilirubin levels.
Findings:
- Pyruvate kinase deficiency can lead to significant hemolytic anemia and jaundice in neonates.
- Prompt recognition and intervention are crucial for managing complications like aplastic crisis.
Implications:
- Family practitioners can manage neonatal hyperbilirubinemia and pyruvate kinase deficiency with appropriate monitoring and timely specialist referrals.
- Early detection of anemia or aplastic crisis may necessitate blood transfusions or splenectomy.
Abstract:
We report an infant with neonatal hyperbilirubinemia due to pyruvate kinase deficiency. The initial approach involved rapid evaluation, phototherapy, and close monitoring of serum bilirubin levels. Follow-up included maintenance on folic acid, monitoring blood counts, and educating the parents about the course of pyruvate kinase deficiency, especially aplastic crisis. We suggest that the informed family practitioner can manage neonatal hyperbilirubinemia and pyruvate kinase deficiency with referrals at critical times to pediatric or surgical specialists. The practitioner must be able to recognize quickly the need for exchange transfusion for severe jaundice and for blood transfusions or splenectomy when significant anemia or aplastic crisis occurs.